Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

Bibliographic Details
Main Authors:	Taylor, Graham P, Goon, Peter, Furukawa, Yoshitaka, Green, Hannah, Barfield, Anna, Mosley, Angelina, Nose, Hirohisa, Babiker, Abdel, Rudge, Peter, Usuku, Koichiro, Osame, Mitsuhiro, Bangham, Charles RM, Weber, Jonathan N
Format:	Online
Language:	English
Published:	BioMed Central 2006
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590049/

Similar Items

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
by: Cong, Yu, et al.
Published: (2016)

Quantification of the virus-host interaction in human T lymphotropic virus I infection
by: Asquith, Becca, et al.
Published: (2005)

Zidovudine.
by: Sperling, R
Published: (1998)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
by: Hodson, Andrew, et al.
Published: (2014)

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
by: Gitta, PK, et al.
Published: (2010)

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
by: Gray, Lachlan R., et al.
Published: (2013)

A Caucasian Australian presenting with human T-lymphotropic virus type I associated myelopathy: a case report
by: Faull, Matthew, et al.
Published: (2014)

Zidovudine-induced myopathy
by: Wiwanitkit, Viroj
Published: (2011)

Clinical Pathophysiology of Human T-Lymphotropic Virus-Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Yamano, Yoshihisa, et al.
Published: (2012)

Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings
by: Petscavage, Jonelle M., et al.
Published: (2015)

Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy
by: Buell, Kevin, et al.
Published: (2015)

Electrophysiological Analysis Shows Dizziness as the First Symptom in Human T Cell Lymphotropic Virus Type-Associated Myelopathy/Tropical Spastic Paraparesis
by: Labanca, Ludimila, et al.
Published: (2015)

Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives
by: Sá, Katia N, et al.
Published: (2015)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
by: Martin, Fabiola, et al.
Published: (2014)

KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
by: Seich al Basatena, Nafisa-Katrin, et al.
Published: (2011)

Zidovudine-induced myopathy: A study in Indian patients
by: Sagar, Amitabh, et al.
Published: (2010)

A case of zidovudine induced pigmentation on palms and soles
by: Singh, Satyendra Kumar, et al.
Published: (2014)

Effect of Zidovudine and its Interaction with Rocuronium on Neuromuscular Transmission
by: Barvaliya, M. J., et al.
Published: (2013)

Intracellular pharmacokinetic study of zidovudine and its phosphorylated metabolites
by: Mu, Lingli, et al.
Published: (2016)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
by: Hodson, Andrew, et al.
Published: (2011)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Kirk, Paul DW, et al.
Published: (2011)

Exposure of Allium cepa Root Cells to Zidovudine or Nevirapine Induces Cytogenotoxic Changes
by: Onwuamah, Chika K., et al.
Published: (2014)

Foetal Loss and Enhanced Fertility Observed in Mice Treated with Zidovudine or Nevirapine
by: Onwuamah, Chika K., et al.
Published: (2014)

Lamivudine-Induced Liver Injury
by: Olaniyan, Lamidi W. B., et al.
Published: (2015)

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial
by: Nakamura, Tatsufumi, et al.
Published: (2013)

Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
by: Kira, Jun-ichi
Published: (2013)

Recurrent Spontaneous Rupture of the Urinary Bladder in a Patient With Human T-lymphotropic Virus Type 1-Associated Myelopathy: A Case Report and Literature Review
by: Feizzadeh Kerigh, Behzad, et al.
Published: (2014)

Association of IL-10 Gene Polymorphisms and Human T Lymphotropic Virus Type I-Associated Myelopathy/tropical Spastic Paraparesis in North-East of Iran (Mashhad)
by: Shirdel, Abbas, et al.
Published: (2013)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
by: Taylor, Graham P.
Published: (2015)

Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation
by: Tajima, Yasutaka, et al.
Published: (2016)

Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection.
by: Enose-Akahata, Yoshimi, et al.
Published: (2015)

Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives
by: Saito, Mineki, et al.
Published: (2012)

A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial
by: Ulbricht, K.U, et al.
Published: (2011)

Lack of Effect of Lamivudine on Ebola Virus Replication
by: Hensley, Lisa E., et al.
Published: (2015)

Structures of B-Lymphotropic Polyomavirus VP1 in Complex with Oligosaccharide Ligands
by: Neu, Ursula, et al.
Published: (2013)

Human T Lymphotropic Virus and Pulmonary Diseases
by: Apio R. N. Dias, et al.
Published: (2018-08-01)

Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
by: Gillet, Nicolas A., et al.
Published: (2013)

Lamivudine sensitivity - a case report
by: Budamakuntla, Leelavathy, et al.
Published: (2014)

Human T-lymphotropic virus type 1(HTLV-1) integration, HTLV-1-associated infective dermatitis (IDH) and the risk of Adult T cell leukaemia/lymphoma (ATLL)
by: Hlela, Carol, et al.
Published: (2011)

Effect of ribavirin on zidovudine efficacy and toxicity in vitro: A concentration-dependent interaction
by: Sim, S.M., et al.
Published: (1998)